Phase II trial of daily S‐1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101...

por Kawashima, Yosuke, Ishimoto, Osamu, Miyauchi, Eisaku, Sakakibara, Tomohiro, Harada, Toshiyuki, Usui, Kazuhiro, Inoue, Akira, Sugawara, Shunichi
Publicado 2023

Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient Mice

por Nakamura, Akira, Mori, Yuriko, Hagiwara, Koichi, Suzuki, Takuji, Sakakibara, Tomohiro, Kikuchi, Toshiaki, Igarashi, Takayuki, Ebina, Masahito, Abe, Tatsuya, Miyazaki, Junichi, Takai, Toshiyuki, Nukiwa, Toshihiro
Publicado 2003

Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor‐mutant lung cancer

por Tode, Naoki, Kikuchi, Toshiaki, Sakakibara, Tomohiro, Hirano, Taizou, Inoue, Akira, Ohkouchi, Shinya, Tamada, Tsutomu, Okazaki, Tatsuma, Koarai, Akira, Sugiura, Hisatoshi, Niihori, Tetsuya, Aoki, Yoko, Nakayama, Keiko, Matsumoto, Kunio, Matsubara, Yoichi, Yamamoto, Masayuki, Watanabe, Akira, Nukiwa, Toshihiro, Ichinose, Masakazu
Publicado 2017